Article Details
Retrieved on: 2017-12-21 03:07:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>Atika Capital Management Llc decreased Bluebird Bio Inc (<b>NASDAQ</b>:BLUE) stake by 17,000 shares to 8,000 valued at $1.10 million in 2017Q3. It also reduced <b>2U</b> Inc (<b>NASDAQ</b>:<b>TWOU</b>) stake by 8,795 shares and now owns 80,805 shares. Exelixis Inc (<b>NASDAQ</b>:EXEL) was reduced too. Since August 31 ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here